Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Pancreatic cancer: the cystic microbiome under suspicion
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
    • International Microbiota Observatory
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Pancreatic cancer: the cystic microbiome under suspicion
Gastroenterology

Pancreatic cancer: the cystic microbiome under suspicion

Cancer
Oncology Gastroenterology

According to a Swedish study, the pancreatic microbiome could have an inflammatory potential and the growth of oral bacteria in pancreatic cystic lesions could be used as a predictive tool for progression to malignancy.

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
    • International Microbiota Observatory
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

About this article

Created 11 June 2019
Updated 06 October 2021

Thanks to recent improvements in medical imaging, lesions caused by pancreatic cystic neoplasms are detected more and more often. Among them, intraductal papillary mucinous neoplasms (IPNMs) of the pancreas, which can progress to pancreatic cancer, are the most common. The pancreatic microbiota could be involved in many ways in the development of these lesions: 1) cancerous pancreatic tissue is richer in bacteria; 2) bacteria from the Fusobacterium species are associated with a poor prognostic; 3) intracystic bacteria could metabolize gemcitabine, thus reducing therapeutic effects of this anticancer drug.

Characterizing the cystic microbiome

A retrospective study has previously tried to characterize the microbiome found in different cysts, but showed no significant results, maybe because the methodology used could have induced contamination (samples were collected through the mouth and esophagus). To resolve the uncertainty, a prospective study was recently carried out, based on samples of cystic liquid and plasma collected during pancreatic resection in 105 patients at the Karolinska hospital in Sweden: 21 non-IPMN cysts, 57 IPMN cysts and 27 malignant IPMN cysts were diagnosed post hoc.

More bacteria and inflammation

Results show that patients diagnosed as carriers of an IPMN (whether it is malignant or not) have higher amounts of bacterial DNA and an increased level of IL-1β (pro-inflammatory interleukin) in the cystic liquid, compared to non-carriers. This correlation is not found in plasma, thus suggesting a local process limited to the cyst. Despite a strong individual variability of the intracystic microbiota composition, the study underlines that cysts occur simultaneously and show increased levels of some oral bacteria, such as Fusobacterium nucleatum and Granulicatella adiacens. Finally, clinical history indicates a strong presence of intracystic bacterial DNA associated, among others, to previous endoscopic lesions related to invasive procedures. However, this increase was independent from the use of proton pump inhibitors (PPI) and antibiotics.

Therapeutic outlooks

Although these results still require additional work, they suggest that some oral bacteria play a role in the development of cysts that are precursors to pancreatic cancer. Although it is too early to imagine a predictive test for pancreatic cancer based on intracystic bacterial DNA, the authors underline that the pancreatic microbiome could be eventually used to treat patients. The interest of the use of antibiotics and the impact of invasive procedures are among the avenues to explore.

Sources

Gaiser RA, Halimi A, Alkharaan H et al. Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer. Gut. 2019 Dec;68(12):2186-2194.

 

Tags
Predictor Pancreatic cancer Cyst Pancreas Cancer

en_view en_sources

    Created 11 June 2019
    Updated 06 October 2021

    About this article

    To know more about this topic.

    Main topic

    Cancer

    Medical practice

    Oncology Gastroenterology

    Content type

    News
    Gastroenterology

    Your IBS Diagnosis Check List

    How many patients suffering from gut disorder do you see per week? How many are diagnosed with Irritable Bo...

    Find out more

    A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumours

    COMMENTED ARTICLE - ADULTS’ SECTION By Pr. Harry SokolGa...

    Find out more

    Gut Microbiota #18

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, University of ...

    Find out more

    Rural environment reduces allergic inflammation by modulating the gut microbiota

    COMMENTED ARTICLE - Children’s section By Pr.Emmanuel Ma...

    Find out more

    Covid-19 & the gut microbiota

    OverviewBy Pr. Tao ZuoSYSU Research Institute of Gastroenterology, Guangdong Institute of Gastroenterology,...

    Find out more

    Artificial sweeteners, gut microbiota and metabolic health: an interaction requiring close examination

    By Pr. Karine ClémentSorbonne University, Inserm, Unité d...

    Find out more

    Highlights of Gut Microbiota for Health - World Summit 2023

    By Dr. Nicolas BenechGastroenterology and hepatology, Microbiota Study Group, Hospices Civils de Lyon, Lyon...

    Find out more

    Everything you need to know about Irritable Bowel Syndrome (IBS)

    Accrediting training, infographics, expert’s video, thematic folder, news… Biocodex Microbiota Institute pr...

    Find out more

    Continue reading

    News
    26.07.2023

    Unexpected effect of famous antibiotic on fungal microbiota

    Read the article
    L’axe intestin-cerveau dans le stress lié à la discrimination
    20.03.2023

    The gut-brain axis and discrimination-related stress

    Read the article
    21.09.2023

    The mucin-microbiota pair - central to the development of gastric cancer?

    Read the article
    25.10.2022

    Antibiotics: Dr Jekyll and Mr Hyde

    Read the article
    13.09.2023

    Parkinson’s disease: Desulfovibrio bacteria have been found guilty

    Read the article
    18.11.2020

    Gut microbiota signature for cirrhosis

    Read the article
    29.08.2023

    Massive amounts of antibiotic resistance genes found in clouds

    Read the article
    29.08.2023

    Ulcerative colitis: a randomized controlled trial highlights the positive effects of the Mediterranean diet

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    Microbiota 17 EN
    Check out our latest magazine
    The first 1000 days of life
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
      • International Microbiota Observatory
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian
    • Portuguese

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
      • International Microbiota Observatory
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    21.09.2023

    The mucin-microbiota pair - central to the development of gastric cancer?

    Read the article
    13.09.2023

    Parkinson’s disease: Desulfovibrio bacteria have been found guilty

    Read the article
    29.08.2023

    Massive amounts of antibiotic resistance genes found in clouds

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
      • International Microbiota Observatory
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo